ArticleClinical rheumatology2023

Retrospective comparative study of the efficacy of JAK inhibitor (tofacitinib) in the treatment of systemic sclerosis-associated interstitial lung disease.

Zhou Junfei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.